Letters to the Editor
Study Confirms Protective Value of Influenza Vaccination
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2012 Feb 1;85(3):218.
to the editor: In early March 2011, one-fourth of the attendees at a business meeting became ill with influenza-like symptoms. The meeting organizer sought immediate care from the hotel physician and subsequently the company medical leadership. Several persons were clinically diagnosed with influenza. Anecdotally, many of those who became ill had not received a seasonal influenza vaccination. After obtaining Institutional Review Board approval, we e-mailed a short questionnaire to the meeting participants to better understand the relationship between their symptoms and their vaccination patterns.
We collected information regarding the demographics of the participants; symptoms of influenza, the common cold, and allergies; and their vaccination status. A total of 122 persons responded to the questionnaire, representing 85 percent of the meeting attendees. The respondents represented 10 countries, with the majority from the United States and Germany. One-half of the participants were younger than 31 years, most were men, and most traveled more than three hours to attend the meeting. Forty-seven percent of the respondents had been vaccinated for influenza in the past 12 months.
For the purposes of analysis, influenza was defined as having more than two of the following symptoms: headache, fatigue, aches, or fever. Twelve participants met our definition of influenza and most of these (83 percent) had not received an influenza vaccination. The resulting odds ratio of 5.0 for vaccination was unlikely to be due to chance (95% confidence interval, 1.0 to 23.1).
A vaccination program for the seasonal and the novel influenza A (H1N1) virus is provided free-of-charge to all employees of The Dow Chemical Company and their spouses throughout U.S. locations and with similar programs worldwide. Despite messages from the company and local health agencies about the value of vaccination, there is still room for improvement in vaccination rates. This study of a cluster of influenza-related illness confirms that vaccination is protective. It also demonstrates the disruptive nature of influenza in business. Results of this study are being communicated company-wide to encourage all employees to be vaccinated during the current influenza season.
Author disclosure: No relevant financial affiliations to disclose.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions